Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q4 FY23 results · Jan–Mar 2023
Bajaj Healthcare reported revenue from operations of ₹158.44 crore (down 9.8% from Q4 FY22) and net profit of ₹3.59 crore (down 79.4% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a standalone basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 158.44 | 175.71 | −9.8% | 141.88 | +11.7% |
| Other income | 0.72 | 0.45 | +61.5% | 0.07 | +904.0% |
| Total income | 159.17 | 176.16 | −9.6% | 141.96 | +12.1% |
| Profit before tax | 5.00 | 16.93 | −70.5% | 15.04 | −66.7% |
| Net profit for the period | 3.59 | 17.47 | −79.4% | 11.05 | −67.5% |
| EPS, basic (₹) | 1.30 | 6.33 | −79.5% | 4.01 | −67.6% |
| Net margin (%) | 2.3 | 9.9 | 7.8 |
Standalone
- Filed with BSE
- 31 May 2023, 16:16 IST
- Board meeting
- 30 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE